Impact of charge patches on tumor disposition and biodistribution of therapeutic antibodies

被引：0
作者：
Jakob C. Stüber
Karin F. Rechberger
Saša M. Miladinović
Thomas Pöschinger
Tamara Zimmermann
Remi Villenave
Miro J. Eigenmann
Thomas E. Kraft
Dhaval K. Shah
Hubert Kettenberger
Wolfgang F. Richter
机构：
[1] Roche Diagnostics GmbH,Roche Pharma Research and Early Development, Roche Innovation Center Munich
[2] Present address: Formycon AG,Roche Pharma Research and Early Development, Roche Innovation Center Basel
[3] F. Hoffmann-La Roche Ltd.,Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences
[4] The State University of New York at Buffalo,undefined
来源：
AAPS Open | / 8卷 / 1期
关键词：
Monoclonal antibodies; Biodistribution; Charge dependence;
D O I：
10.1186/s41120-021-00048-9
中图分类号：
学科分类号：
摘要：
This study explores the impact of antibody surface charge on tissue distribution into various tissues including tumor. Tumor-bearing mice were dosed intravenously with a mixture comprising three antibodies engineered to carry negative charge patches, a balanced charge distribution, or positive patches, respectively (cassette dosing). Tissue levels were analyzed with a specific LC-MS/MS method. In addition, the antibody mix was administered to non-tumor bearing mice. Muscle and skin interstitial fluid were obtained by centrifugation and analyzed by LC-MS/MS. An in vitro endothelium model was explored for its feasibility to mimic the observed distribution differences.
引用
收藏
相关论文
共 189 条
  • [1] Acqua WFD(2002)Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences J Immunol. 169 5171-5180
  • [2] Woods RM(1989)Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection Microvasc Res. 37 77-104
  • [3] Ward ES(2010)Effects of charge on antibody tissue distribution and pharmacokinetics Bioconjugate Chem. 21 2153-2163
  • [4] Palaszynski SR(2017)Beyond the Debye length in high ionic strength solution: direct protein detection with field-effect transistors (FETs) in human serum Sci Rep-uk. 7 5256-955
  • [5] Patel NK(2019)An in vitro FcRn-dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans Mabs. 11 942-493
  • [6] Brewah YA(2020)The biodistribution of therapeutic proteins: mechanism, implications for pharmacokinetics, and methods of evaluation Pharmacol Therapeut. 212 107574-1518
  • [7] Baxter LT(2015)Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics Mabs. 7 483-124
  • [8] Jain RK(2002)Comparison of IgG diffusion and extracellular matrix composition in rhabdomyosarcomas grown in mice versus in vitro as spheroids reveals the role of host stromal cells Brit J Cancer. 86 6600270-7330
  • [9] Boswell CA(2000)Vascular permeability in a human tumour xenograft: molecular charge dependence Brit J Cancer. 82 1513-115
  • [10] Tesar DB(2013)Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies Clin Pharmacokinet. 52 83-709
12345678910